PrimeRFP
PrimeRFP SCOUT · IDV / contract family

75N91019D00024IDV family

IDIQ 75N91019D00024 - 72 task orders is a federal IDV / contract family. SCOUT maps 72 distinctive task orders, with $2.6B obligated on the IDV rollup.

Nih Nci
Awarding office
Through Jan 28, 2031
Period
$2.6B
IDV obligated
72
Task orders

Watch this IDV family

One email. No account. We ping you when orders or incumbents under this IDV move.

Score my firm on this vehicle family — $90

Family facts

IDV
Parent PIID75N91019D00024
AgencyNih Nci
Awarding officeNih Nci
Awarding agencyDepartment of Health and Human Services (HHS)
Period endJan 28, 2031
IDV obligated$2.6B
Child awards72

Places of performance

States

MD

Distinctive task orders

12
75N91020F00003 — THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVI…
Leidos Biomedical Research, Inc. · $1.8B · PoP Jun 20, 2025
75N91020F00004 — NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER
Leidos Biomedical Research, Inc. · $297.6M · PoP Jan 26, 2026
75N91020F00039 — NIAID COVID-19 ACTIV3
Leidos Biomedical Research, Inc. · $281.6M · PoP Sep 29, 2029
75N91019F00139 — MD NET
Leidos Biomedical Research, Inc. · $163.5M · PoP Sep 29, 2028
75N91021F00004 — ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
Leidos Biomedical Research, Inc. · $141.7M · PoP Jan 28, 2031
75N91020F00006 — NIAID VRC
Leidos Biomedical Research, Inc. · $125.8M · PoP Nov 29, 2024
75N91020F00025 — DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEO…
Leidos Biomedical Research, Inc. · $97.5M · PoP Sep 24, 2028
75N91020F00001 — FY20 FACILITIES TASK ORDER A REFURBISHMENT AND INFRASTRUCTURE PROJECTS FOCUSED ON FACILITY IMPROVEMENTS WITHIN THE NCI…
Leidos Biomedical Research, Inc. · $95.9M · PoP Jan 31, 2026
75N91020F00009 — ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED…
Leidos Biomedical Research, Inc. · $89.6M · PoP Jul 31, 2028
75N91020F00010 — INITIATE THE MANAGEMENT, OVERSIGHT, AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL TITLED "A MULTICENTER, ADAPTIVE, RANDO…
Leidos Biomedical Research, Inc. · $83.4M · PoP Apr 2, 2025
75N91021F00013 — ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Leidos Biomedical Research, Inc. · $81.1M · PoP Aug 31, 2026
75N91020F00011 — NIAID DMID BIG EFFECT TRIAL (BET) - INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DMID CLINICAL TRIAL…
Leidos Biomedical Research, Inc. · $62.1M · PoP Nov 29, 2024

Seen enough? Run one full capture cycle on 75N91019D00024 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record family rollup + SCOUT analysis; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91019D00024